“Dupilumab-Treated Patients With Prurigo Nodularis Report Disease Control and Treatment Satisfaction: 6-Month Results From the RELIEVE-PN Study”, J of Skin, vol. 9, no. 6, p. s716, Nov. 2025, doi: 10.25251/h522p595.